PetDx is a molecular diagnostics startup focused on the development of breakthrough non-invasive “liquid biopsy” tests for the early detection, characterization, and management of cancer in pets. Founded by Daniel Grosu, former CMO of Illumina and Sequenom. PetDx is initially focused on the leading cause of death in dogs: cancer.
